Patents by Inventor Philip Harvey
Philip Harvey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11138475Abstract: Systems and methods for data protection are disclosed. In one embodiment, in an information processing apparatus comprising at least one computer processor, a method for providing data protection may include: (1) receiving a plurality of data classification rules; (2) receiving end user data classification from end user software; (3) receiving developer data classification from SDLC software; (4) generating a data inventory; and (5) applying at least one data protection to the data inventory based on the data classification rules, the end user data classification, and the developer data classification.Type: GrantFiled: March 1, 2019Date of Patent: October 5, 2021Assignee: JPMORGAN CHASE BANK, N.A.Inventors: Matthew Jesse Collins, David MacFarlane, Sean Thomas Kornish, Jorge Garcia Reyero, Philip Harvey
-
Patent number: 10844349Abstract: The invention relates to a new formulation of albumin, a method for producing the albumin formulation and to uses of the albumin formulation, for example in cell culture such as mammalian cell culture and particularly in stem cell culture.Type: GrantFiled: July 5, 2012Date of Patent: November 24, 2020Assignee: Albumedix Ltd.Inventors: Sandra Marie Merkel, Luke Dimasi, Collette Ann Sheahan, Philip Harvey Morton
-
Publication number: 20200279139Abstract: Systems and methods for data protection are disclosed. In one embodiment, in an information processing apparatus comprising at least one computer processor, a method for providing data protection may include: (1) receiving a plurality of data classification rules; (2) receiving end user data classification from end user software; (3) receiving developer data classification from SDLC software; (4) generating a data inventory; and (5) applying at least one data protection to the data inventory based on the data classification rules, the end user data classification, and the developer data classification.Type: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Inventors: Matthew Jesse Collins, David MacFarlane, Sean Thomas Kornish, Jorge Garcia Reyero, Philip Harvey
-
Patent number: 9555344Abstract: A process is provided for the preparation of a highly pure albumin solution the process comprising subjecting albumin (preferably expressed and secreted by transformed yeast) to a series of chromatographic steps. Preferably, the process comprises the steps of positive mode cation exchange chromatography, positive mode anion exchange chromatography, positive mode affinity chromatography, negative mode affinity chromatography (preferably using immobilized aminophenylboronic acid), negative mode cation exchange chromatography, and negative or positive mode anion exchange chromatography. A process for reducing the level of nickel in an albumin solution is also disclosed, as is a recombinant albumin coding sequence comprising two or more in-frame translation stop codons.Type: GrantFiled: July 14, 2014Date of Patent: January 31, 2017Assignee: Albumedix A/SInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, David James Ballance, Darrell Sleep
-
Patent number: 9029102Abstract: A process is provided for the preparation of a highly pure albumin solution the process comprising subjecting albumin (preferably expressed and secreted by transformed yeast) to a series of chromatographic steps. Preferably, the process comprises the steps of positive mode cation exchange chromatography, positive mode anion exchange chromatography, positive mode affinity chromatography, negative mode affinity chromatography (preferably using immobilized aminophenylboronic acid), negative mode cation exchange chromatography, and negative or positive mode anion exchange chromatography. A process for reducing the level of nickel in an albumin solution is also disclosed, as is a recombinant albumin coding sequence comprising two or more in-frame translation stop codons.Type: GrantFiled: July 1, 2011Date of Patent: May 12, 2015Assignee: Novozymes Biopharma DK A/SInventors: Hendrik Van Urk, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michael Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Jean-Luc Bernard Veron
-
Publication number: 20150056654Abstract: A process is provided for the preparation of a highly pure albumin solution the process comprising subjecting albumin (preferably expressed and secreted by transformed yeast) to a series of chromatographic steps. Preferably, the process comprises the steps of positive mode cation exchange chromatography, positive mode anion exchange chromatography, positive mode affinity chromatography, negative mode affinity chromatography (preferably using immobilised aminophenylboronic acid), negative mode cation exchange chromatography, and negative or positive mode anion exchange chromatography. A process for reducing the level of nickel in an albumin solution is also disclosed, as is a recombinant albumin coding sequence comprising two or more in-frame translation stop codons.Type: ApplicationFiled: July 14, 2014Publication date: February 26, 2015Inventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michael Gaston Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-luc Bernard Veron
-
Publication number: 20140234966Abstract: The invention relates to a new formulation of albumin, a method for producing the albumin formulation and to uses of the albumin formulation, for example in cell culture such as mammalian cell culture and particularly in stem cell culture.Type: ApplicationFiled: July 5, 2012Publication date: August 21, 2014Applicant: NOVOZYMES BIOPHARMA DK A/SInventors: Sandra Marie Merkel, Luke Dimasi, Collette Ann Sheahan, Philip Harvey Morton
-
Publication number: 20110301329Abstract: A process is provided for the preparation of a highly pure albumin solution the process comprising subjecting albumin (preferably expressed and secreted by transformed yeast) to a series of chromatographic steps. Preferably, the process comprises the steps of positive mode cation exchange chromatography, positive mode anion exchange chromatography, positive mode affinity chromatography, negative mode affinity chromatography (preferably using immobilised aminophenylboronic acid), negative mode cation exchange chromatography, and negative or positive mode anion exchange chromatography. A process for reducing the level of nickel in an albumin solution is also disclosed, as is a recombinant albumin coding sequence comprising two or more in-frame translation stop codons.Type: ApplicationFiled: July 1, 2011Publication date: December 8, 2011Applicant: Novozymes Biopharma DK A/SInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
-
Patent number: 7993877Abstract: A process is provided for the preparation of a highly pure recombinant albumin solution having a nickel ion content of less than 100 ng per gram of albumin. The process comprises subjecting a recombinant albumin to a series of chromatography, concentration, and diafiltration steps.Type: GrantFiled: September 9, 2008Date of Patent: August 9, 2011Assignee: Novozymes Biopharma DK A/SInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
-
Publication number: 20090171070Abstract: A process is provided for the preparation of a highly pure recombinant albumin solution having a nickel ion content of less than 100 ng per gram of albumin. The process comprises subjecting a recombinant albumin to a series of chromatography, concentration, and diafiltration steps.Type: ApplicationFiled: September 9, 2008Publication date: July 2, 2009Applicant: NOVOZYMES BIOPHARMA UK LIMITEDInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
-
Patent number: 7098703Abstract: An electronic logic driver circuit, for driving a capacitive load between supply potentials for example for use in driving logic circuit elements on or off a chip, is disclosed. The driver circuit comprises switching devices to switch current either to or from two main voltage supply sources and two coupled inductors that act to store energy derived from the voltage sources. In operation, the coupled inductors form an LC resonator with the load such that energy stored in the inductors can be transferred to or from the load to drive a change in the voltage of the load.Type: GrantFiled: April 24, 2002Date of Patent: August 29, 2006Assignee: Midas Green LimitedInventor: Geoffrey Philip Harvey
-
Publication number: 20040145411Abstract: An electronic logic driver circuit, for driving a capacitive load between supply potentials for example for use in driving logic circuit elements on or off a chip, is disclosed. The driver circuit comprises switching devices to switch current either to or from two main voltage supply sources and two coupled inductors that act to store energy derived from the voltage sources. In operation, the coupled inductors form an LC resonator with the load such that energy stored in the inductors can be transferred to or from the load to drive a change in the voltage of the load.Type: ApplicationFiled: March 24, 2004Publication date: July 29, 2004Inventor: Geoffrey Philip Harvey
-
Patent number: 6696688Abstract: An apparatus is provided for one-dimensional magnetic scanning or switching of a charged particle beam. The apparatus can be extended to two dimensions at the cost of added complexity.Type: GrantFiled: September 7, 2001Date of Patent: February 24, 2004Assignee: Diamond Semiconductor Group, LLCInventors: Nicholas White, Edward Bell, Philip Harvey
-
Publication number: 20020109099Abstract: An apparatus is provided for one-dimensional magnetic scanning or switching of a charged particle beam. The apparatus can be extended to two dimensions at the cost of added complexity.Type: ApplicationFiled: September 7, 2001Publication date: August 15, 2002Applicant: Diamond Semiconductor Group, LLCInventors: Nicholas White, Edward Bell, Philip Harvey